Download presentation
Presentation is loading. Please wait.
Published byRafe Mills Modified over 9 years ago
1
Modern Management of Prolonged Rupture of Membranes Joseph R. Biggio Jr., M.D. Department of Obstetrics & Gynecology Division of Maternal-Fetal Medicine University of Alabama at Birmingham
2
PROM Amniorrhexis prior to onset of active labor regardless of gestational age Premature Rupture of Membranes
3
PPROM Amniorrhexis < 37 weeks’ gestational age prior to onset of active labor Preterm Premature Rupture of Membranes
4
Latency Interval from Rupture of Membranes to Onset of Active Labor
5
Diagnosis l History l Avoid digital exam l Vaginal Pool l Nitrazine Paper l Ferning l Ultrasound l Amniocentesis/Dye Study
6
PROM near Term l Management gestational age dependent l Induction vs. awaiting spontaneous labor l Antibiotic prophylaxis per ACOG/CDC recommendations
7
Induction vs. Expectant Management l >5,000 women randomized n Oxytocin, PGE2 or expectant management up to 4 days n No difference in cesarean section or neonatal infection n Less chorioamnionitis in induction with oxytocin group Hannah, NEJM, 1996
8
Epidemiology of Preterm Birth PPROM Spontaneous Preterm Delivery Indicated Preterm Delivery 28 % 46 % 26 % Andrews, 1995
9
PPROM Risk Factors l Lower/Upper Genital Tract Infection Proteases Prostaglandins l History of PPROM l Incompetent Cervix l Abruption l Polyhydramnios l Multiple Gestation l Smoking
10
PPROM Complications l Maternal/Fetal Infection l Premature Labor and Delivery l Umbilical Cord Prolapse l Fetal Hypoxia 2º Cord Compression l Increased Rate of Cesarean Section l Intrauterine Growth Restriction l Abruption l Stillbirth
11
PPROM Standard Management l Confirmation of Diagnosis l Verification of Gestational Age l R/O Labor/Infection/Fetal Compromise l Avoid Digital Vaginal Examinations l In Hospital Observation l Bedrest
12
PPROM Latency Gestational Age (Weeks) % Patients with Latency > 1 Week 25 50 75 0 Wilson, Obstetrics & Gynecology, 1982
13
PPROM Vaginal Examination Gestational Age (Weeks) 20 15 10 5 Latency Days No Exam Exam Lewis, Obstetrics & Gynecology, 1992
14
Previable PPROM l < 24 weeks l Poor prognosis for successful outcome l Outcome may be different for spontaneous vs. iatrogenic
15
Previable PPROM Complications l Uterine Infection l Pulmonary Hypoplasia l Limb Compression Deformities l Intrauterine Growth Restriction
16
Previable PPROM Outcomes
17
PPROM Management Issues Timing of Delivery l Tocolysis l Antibiotics l Steroids l Amniocentesis l Observation vs. Induction l Fetal Lung Maturity Testing l Fetal Surveillance
18
Timing of Delivery
19
Neonatal Morbidity/Mortality UAB (1995-1996) %
20
RNICU Survival and Morbidity Data (1995-1996) % Neonates
21
Tocolysis
22
PPROM Tocolysis Weiner, AJOG, 1988
23
PPROM Tocolysis Garite, AJOG, 1987
24
Antibiotics
25
Preterm Labor Chorioamnion Colonization 0 30 weeks 31- 34 weeks 34- 36 weeks 37 weeks 25 50 75 % Patients Colonized Spontaneous Preterm Labor Indicated Cassell, 1993
26
PPROM Antibiotic Therapy l Reduction Maternal/Perinatal Infection l Prolong Latency Period l Improve Neonatal Outcome
27
Antibiotic: PPROM NIH-MFM Network Study l PPROM between 24 and 32 weeks l IV ampicillin and erythromycin for 48 h l Oral amoxicillin/erythromycin for 5 days l Identification and Rx of GBS carriers l Tocolysis and corticosteroids prohibited Mercer, JAMA, 1997
28
Antibiotic: NIH-MFM Network Study Neonatal Morbidity * * *
29
Antibiotic: Latency Period NIH-MFM Network Study
30
PPROM Antibiotic Therapy l Optimal Antibiotic Regimen l Route/Duration of Administration
31
Antibiotics & PPROM: Summary l Reduction in maternal infectious morbidity l Reduction in births <48 h and <7 d l Reduction in neonatal infectious morbidity l Reduction in neonates requiring NICU and ventilation >28 d Kenyon, Cochrane Library, 1999
32
Antibiotics & PPROM: Summary l No clear reduction in perinatal death l No clear reduction in cerebral abnormalities Kenyon, Cochrane Library, 1999
33
Amniocentesis
34
PPROM Amniotic Fluid Culture l Group B Streptococcus20 % l Gardnerella vaginalis17 % l Peptostreptococcus11 % l Fusobacteria10 % l Bacteroides fragilis 9 % l Other Streptococci 9 % l Bacteroides sp. 5 %
35
Utility of Amniocentesis l Confirm/Refute diagnosis of chorioamnionitis Glucose <15 mg/dL Culture Gram stain l Lung maturity testing
36
Corticosteroids
37
Corticosteroids for FLM l Betamethasone l Dexamethasone
38
PPROM Corticosteroids Block Taeusch Papageorgiou Young Garite Collaborative Iams Nelson Simpson Morales 43 17 38 80 153 38 22 112 121 26 24 19 37 80 135 35 46 105 124 AuthorSteroidsControl Effect on RDS Number of Patients
39
PPROM Corticosteroids Crowley, Ob/Gyn Clinics, 1992 *
40
PPROM Corticosteroids + Antibiotics * Lewis, Obstetrics & Gynecology, 1996
41
1994 NIH Consensus Conference: Corticosteroids in PPROM l Corticosteroids reduce incidence/severity of RDS, IVH l Benefits in PPROM up to 30-32 weeks l No significant adverse outcomes for corticosteroid use in PPROM l Impact less than with intact membranes
42
Observation vs. Induction
43
Neonatal Morbidity/Mortality UAB (1995-1996) %
44
PPROM Observation vs. Induction Mercer, AJOG, 1993 * *
45
PPROM Observation vs Induction Cox, Obstetrics & Gynecology, 1995
46
Fetal Lung Maturity Testing
47
Fetal Lung Maturation Biologic Markers 8 6 4 2 00 4 2 6 8 202428323640 Gestational Age (weeks) L:S Ratio % Phospholipid L:S PI PG 10
48
Fetal Lung Maturity Evaluation in Vaginal Pool Specimen l L:S RatioNot Reliable l TDX:FLM AssayNot Validated l PGUseful
49
Fetal Surveillance
50
PPROM Fetal Surveillance l Daily Non-Stress Test (NST) Variables Tachycardia Loss of reactivity l Biophysical Profile (BPP) l Contraction Stress Test (CST)
51
Summary
52
UAB Management of PPROM PPROM 34 weeks Deliver Previable PROM Outpatient observation Antibiotic prophylaxis Option of termination <22wk Admission at viability
53
PPROM 23 weeks, <34 weeks Antibiotic prophylaxis: Amoxicillin 500 tid x 10d, Azithromycin 1gm d1 & d5 1 course Betamethasone if <32weeks Test for pool PG weekly beginning at 32 weeks Deliver at 34-35 weeks UAB Management of PPROM
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.